Angiotensin II in experimental hyperdynamic sepsis
Open Access
- 1 January 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 13 (6), R190
- https://doi.org/10.1186/cc8185
Abstract
Angiotensin II (Ang II) is a potential vasopressor treatment for hypotensive hyperdynamic sepsis. However, unlike other vasopressors, its systemic, regional blood flow and renal functional effects in hypotensive hyperdynamic sepsis have not been investigated.Keywords
This publication has 37 references indexed in Scilit:
- Renal haemodynamic, microcirculatory, metabolic and histopathological responses to peritonitis-induced septic shock in pigsCritical Care, 2009
- Renal blood flow in experimental septic acute renal failureKidney International, 2006
- Lung, Spleen, and Kidney Are the Major Places for Inducible Nitric Oxide Synthase Expression in Endotoxic Shock: Role of P38 Mitogen-Activated Protein Kinase in Signal Transduction of Inducible Nitric Oxide Synthase ExpressionShock, 2004
- Transient receptor potential channels in rat renal microcirculation: Actions of angiotensin IIKidney International, 2002
- Angiotensin for septic shock unresponsive to noradrenalineArchives of Disease in Childhood, 2000
- Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious ratsBritish Journal of Pharmacology, 1998
- PROLONGED SYSTEMIC AND REGIONAL HAEMODYNAMIC EFFECTS OF INTRACEREBROVENTRICULAR ANGIOTENSIN II IN CONSCIOUS SHEEPClinical and Experimental Pharmacology and Physiology, 1996
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992
- Reversal of renal cortical actions of angiotensin II by verapamil and manganeseKidney International, 1979
- A Mechanism for Vasodilatation in the KidneyAnnals of Surgery, 1973